Skip to content

Shuji Murakami

Institut Gustave Roussy

1 paper in the Anchorcite directory, published in 2017, cited 4,715 times in total.

ORCID profile

Research topics

Frequent co-authors

  • Scott Joseph Antonia · 1 paper
  • Augusto E. Villegas · 1 paper
  • Davey B. Daniel · 1 paper
  • David Vicente · 1 paper
  • Rina Hui · 1 paper
  • Takashi Yokoi · 1 paper
  • Alberto Chiappori · 1 paper
  • Ki Hyeong Lee · 1 paper

Papers

  1. Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung CancerNew England Journal of Medicine · 2017 · 4,715 citations

    BACKGROUND: Most patients with locally advanced, unresectable, non-small-cell lung cancer (NSCLC) have disease progression despite definitive chemoradiotherapy (chemotherapy plus concurrent radiation therapy). This phase 3 study compared the anti-programmed death ligand 1 antibody durvalumab as consolidation therapy with placebo in…

Metadata from OpenAlex (CC0).